Tibial Plateau Fracture: Medications and Pharmacy Lien Coverage

James Wong — Founder & Pharmacist, LienScripts | February 21, 2026 | 8 min read

Tibial plateau fractures from MVA and pedestrian accidents require ORIF surgery and a 12+ month medication arc covering severe post-surgical pain, DVT prophylaxis, nerve injury, and long-term joint protection. A pharmacy lien covers every phase.

Tibial Plateau Fractures in Personal Injury Cases

The tibial plateau — the broad, flat upper surface of the tibia that forms the lower half of the knee joint — is one of the most structurally critical weight-bearing surfaces in the human body. When this surface fractures, the consequences extend far beyond the bone itself: the fracture disrupts articular cartilage, destabilizes the knee joint, injures adjacent ligaments and menisci, and compresses or stretches the peroneal and tibial nerves. Recovery is measured in years, not months.

In personal injury (PI) cases, tibial plateau fractures are among the most severe knee injuries a patient can sustain. The mechanism — typically a high-energy lateral impact to a flexed knee — is directly associated with motor vehicle accidents and pedestrian knockdowns. Understanding the injury pattern, the surgical treatment, and the extensive medication arc that follows is essential for patients, treating providers, and PI attorneys building a complete damages case.

Mechanism of Injury: How Tibial Plateau Fractures Happen

The Schatzker classification system divides tibial plateau fractures into six types based on fracture pattern and severity:

• Schatzker I-III: Lateral plateau injuries, typically caused by a valgus force applied to the extended or slightly flexed knee. In motor vehicle accidents, this occurs when the outside of the knee strikes a door panel, wheel well, or another vehicle. In pedestrian accidents, the classic mechanism is a bumper strike directly to the lateral knee.
• Schatzker IV: Medial plateau fractures, which require higher energy and are associated with vascular injury to the popliteal artery — a limb-threatening complication requiring emergency vascular surgery.
• Schatzker V-VI: Bicondylar and complex metaphyseal-diaphyseal fractures, almost always from extremely high-energy mechanisms such as head-on vehicle collisions, motorcycle crashes at speed, or being struck and run over by a vehicle. These fractures involve both the medial and lateral plateau and carry a high complication rate.

The dashboard injury mechanism — knee flexed, foot on the floor, knee striking the dashboard at the moment of impact — is the classic MVA mechanism for tibial plateau fracture. The compressive force is transmitted up through the tibia against the femoral condyle, crushing and splitting the plateau surface.

Surgical Treatment: ORIF and Its Complexity

The standard surgical treatment for displaced tibial plateau fractures is Open Reduction and Internal Fixation (ORIF): surgically opening the fracture site, restoring the plateau's surface anatomy under direct visualization, and securing the reduction with plates, screws, and lag screws.

For Schatzker V-VI fractures, ORIF often proceeds in stages:

1. An initial external fixation procedure to stabilize the limb and allow swelling to subside
2. Definitive ORIF 5-10 days later once soft tissue swelling permits closure without wound compromise

The complexity of the surgical reconstruction directly drives the intensity and duration of the post-operative medication protocol.

[!KEY] Tibial plateau ORIF is not a single surgery — it is frequently a staged intervention spanning two or more operative procedures. The medication arc must be understood in this context: it begins before the definitive surgery and extends 12 months or more beyond it.

Phase 1: Acute Post-Operative Period (Weeks 1-6)

The acute phase after tibial plateau ORIF is characterized by severe pain, major surgical wound care requirements, and an extended period of non-weight-bearing. The medications prescribed reflect this intensity:

Opioid analgesia: Tibial plateau ORIF patients experience substantially more post-operative pain than routine arthroscopic knee patients. Short-acting opioids (oxycodone, hydrocodone) are prescribed for breakthrough pain, and some patients with complex fractures receive scheduled opioid dosing in the initial weeks. Adequate pain control is essential for respiratory compliance, DVT prevention exercises (ankle pumps), and sleep — all of which directly affect recovery outcomes.

Prescription NSAIDs (meloxicam, naproxen): Anti-inflammatory coverage reduces the prostaglandin-driven inflammatory cascade that damages articular cartilage in the peri-fracture period. Timing is guided by the surgeon based on fracture healing considerations.

Muscle relaxants (cyclobenzaprine, methocarbamol): Quadriceps and hamstring spasm following ORIF is painful and can pull on the repaired fracture site. Muscle relaxants reduce this involuntary tension.

Anticoagulants for DVT prophylaxis: This is a medication class unique to tibial plateau fracture cases among typical orthopedic injuries. Tibial plateau fracture patients face an elevated risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) because of:

• The fracture's proximity to the popliteal vein
• Prolonged non-weight-bearing immobility (6-12 weeks)
• Post-surgical hypercoagulable state

Physicians typically prescribe rivaroxaban (Xarelto), apixaban (Eliquis), or enoxaparin (Lovenox injections) for DVT prophylaxis during the non-weight-bearing phase. These are prescription medications dispensed through the pharmacy and represent a significant pharmaceutical component of the post-operative medication arc.

[!SOURCE] Prat-Fabregat et al. (2016) documented that DVT occurs in a substantial proportion of tibial plateau fracture patients without prophylaxis, and that anticoagulant therapy significantly reduces this risk during the prolonged non-weight-bearing period. PMID: 27066489.

Phase 2: Non-Weight-Bearing and Partial Weight-Bearing Phase (Weeks 6-16)

As the fracture consolidates on imaging, protected weight-bearing is gradually introduced. This phase brings a distinct medication profile:

Gabapentin or pregabalin: Peroneal nerve injury co-occurs with tibial plateau fractures in a clinically significant proportion of cases — the common peroneal nerve wraps around the fibular head just below and lateral to the lateral tibial plateau. Fractures and surgical retraction can stretch or compress this nerve, producing foot drop, lateral calf numbness, and burning neuropathic pain. Gabapentin or pregabalin is prescribed to manage this neuropathic component, which may persist for months to years.

Continued anticoagulation: In patients with confirmed DVT or those at elevated risk, anticoagulation may be extended through the weight-bearing transition.

Celecoxib: As the fracture heals and the patient moves into active rehabilitation, celecoxib provides sustained anti-inflammatory support for the articular cartilage and soft tissue reconstruction through the physical therapy phase.

Topical diclofenac: Applied to the knee, topical diclofenac manages localized inflammation with minimal systemic exposure, supplementing systemic anti-inflammatory therapy during the rehabilitation loading phase.

Phase 3: Complications of Non-Weight-Bearing (Weeks 4-12)

Extended non-weight-bearing in a PI patient — often a person who was previously active and employed — creates significant secondary medical needs:

Sleep disruption: Immobility, positional pain, and the psychological stress of a major injury and pending litigation disrupts sleep. Physicians commonly prescribe:

• Trazodone (50-100mg at bedtime): A sedating antidepressant used off-label for sleep that avoids the dependence risk of benzodiazepines
• Hydroxyzine (Vistaril): An antihistamine with sedating and anxiolytic properties, frequently prescribed for the anxiety-sleep comorbidity in prolonged injury recovery

Depression and adjustment disorder: The combination of severe physical limitation, loss of employment capacity, financial stress from the PI case, and prolonged immobility produces clinically significant mood disruption in a significant proportion of tibial plateau fracture patients. When a psychiatrist or primary care physician documents and treats this condition, the prescription record — including SSRIs, SNRIs, or low-dose antidepressants — is part of the complete medical record and relevant to general damages.

[!KEY] Sleep and mood medications prescribed during the non-weight-bearing phase of tibial plateau fracture recovery are injury-related medical treatment, not incidental prescriptions. Their presence in the pharmacy lien record supports the general damages narrative by documenting the injury's impact on quality of life.

Phase 4: Post-Traumatic Arthritis and Long-Term Management (Months 6-18+)

Tibial plateau fractures carry a high rate of post-traumatic osteoarthritis, even when the surgical reduction is anatomically excellent. The articular cartilage damage sustained at the moment of impact — and during the inflammatory period following the fracture — creates a substrate for progressive joint degeneration. Long-term medication needs include:

• Celecoxib or meloxicam: Long-term NSAID therapy for post-traumatic arthritis pain, with gastroprotective coverage
• Topical diclofenac gel: Supplemental localized anti-inflammatory for flare management
• Duloxetine (Cymbalta): FDA-approved for chronic musculoskeletal pain; particularly useful when central sensitization develops in patients with persistent post-traumatic arthritis pain
• Gabapentin continuation: For patients with ongoing peroneal nerve symptoms, gabapentin may be continued indefinitely
• Viscosupplementation injections (hyaluronic acid series): When prescribed for post-traumatic arthritis management, these pharmacy-dispensed injectable preparations are covered under the pharmacy lien

The 12+ Month Medication Arc and the Demand Package

The tibial plateau fracture medication arc is among the longest in common orthopedic PI injuries. A complete pharmacy lien record for a typical complex case includes:

• Post-operative opioids (weeks 1-6)
• Anticoagulants for DVT prophylaxis (weeks 1-12+)
• Muscle relaxants (weeks 1-8)
• Prescription NSAIDs and COX-2 inhibitors (months 1-12+)
• Gabapentin for neuropathic pain (months 2-18+)
• Sleep medications (trazodone, hydroxyzine; months 1-6)
• Mood-related prescriptions if documented (months 2-12)
• Topical anti-inflammatory preparations (months 2-18+)
• Long-term post-traumatic arthritis medications (months 6-18+)

This record, presented in the demand package alongside the surgical operative reports, physical therapy records, and neurology/EMG documentation, creates a medically coherent and comprehensive damages narrative.

[!SOURCE] Barei et al. (2006) demonstrated that post-traumatic arthritis requiring knee arthroplasty occurs in a significant proportion of complex tibial plateau fracture patients within 10 years of injury, establishing the long-term medical care trajectory that supports future medical damages arguments. PMID: 16773147.

How a Pharmacy Lien Works for Tibial Plateau Fracture Patients

PI patients with tibial plateau fractures face acute financial pressure: they are non-weight-bearing for months, often unable to work, and confronting prescription costs that span a year or more. A pharmacy lien resolves this by:

• Dispensing all prescribed medications on credit secured by the pending PI claim
• Requiring no out-of-pocket payment from the patient during recovery
• Creating a date-stamped, sequential prescription record for use in the demand package
• Covering the full arc from post-surgical opioids through long-term anti-arthritis maintenance

The lien is repaid from the eventual settlement or judgment. The patient receives the medications needed for full recovery without financial compromise.

Conclusion

Tibial plateau fractures represent some of the most severe and medically complex lower extremity injuries in the PI caseload. The ORIF surgery, the prolonged non-weight-bearing recovery, the DVT prophylaxis requirements, the neuropathic complications, and the long-term post-traumatic arthritis trajectory collectively produce a medication arc extending 12 months or more. A pharmacy lien ensures that every prescribed medication in that arc is accessible, documented, and presented as part of a complete and persuasive demand package.

Related Resources

• Meniscus Repair Surgery Medications and Pharmacy Lien
• Ankle Fracture Surgery Medications and Pharmacy Lien
• Lumbar Fusion Medications and Pharmacy Lien
• What Is a Pharmacy Lien?